Streetbeat News

Price Targets

AEZS

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on AEterna Zentaris (NASDAQ:AEZS) and maintained a $28 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:47 am

SRRK

HC Wainwright & Co. analyst Andres Maldonado has reiterated a 'Buy' rating on Scholar Rock Holding (NASDAQ:SRRK) and maintained a $30 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:46 am

FA

Barclays analyst Manav Patnaik maintains an Equal-Weight rating on First Advantage (NASDAQ:FA) and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:45 am

LI

Barclays analyst Jiong Shao has maintained an Overweight rating on Li Auto (NASDAQ:LI) and raised the price target from $34 to $48.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:44 am

NVAX

HC Wainwright & Co. analyst Vernon Bernardino has reiterated a 'Buy' rating on Novavax (NASDAQ:NVAX) and maintained a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:43 am

BNTX

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on BioNTech (NASDAQ:BNTX) but lowers the price target from $181 to $180.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:42 am

AADI

HC Wainwright & Co. analyst Robert Burns has reiterated a 'Buy' rating on Aadi Bioscience (NASDAQ:AADI), maintaining a $45 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:41 am

IFF

Barclays analyst Lauren Lieberman maintains an Underweight rating on Intl Flavors & Fragrances (IFF) and lowers the price target from $75 to $60.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:40 am

PODD

Barclays analyst Matt Miksic has maintained an Equal-Weight rating on Insulet (NASDAQ:PODD) and lowered the price target from $329 to $257.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:39 am

IAC

Barclays analyst Ross Sandler has maintained an Overweight rating on IAC (NASDAQ:IAC) but lowered the price target from $85 to $75.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:37 am